Catherine Weiss, PhD

  • 3Articles
  • 20KReads
  • 2019–2023Active
  • 12Collaborators
  • 58Citations

About

Catherine Weiss, PhD, conducted research at Otsuka Pharmaceutical Development & Commercialization Inc. in Princeton, New Jersey, before retiring. Her publications from 2019 to 2023 focus on metabolic changes and body weight in patients treated with adjunctive brexpiprazole for major depressive disorder and prediabetes, as well as the effects of brexpiprazole on functioning in schizophrenia. She frequently collaborated with co-authors including Stine R. Meehan and John W. Newcomer.

Publications

JCP
Brexpiprazole in Patients With MDD and Prediabetes
Original Research

Brexpiprazole in Patients With MDD and Prediabetes

August 28, 2023

Some atypical antipsychotics, while efficacious as adjunctive treatments in major depressive disorder (MDD), can lead to adverse effects and weight gain. Adjunctive brexpiprazole had a limited impact on metabolic...
, , , et al
JCP
Effects of Brexpiprazole on Functioning in Schizophrenia
Original Research

Effects of Brexpiprazole on Functioning in Schizophrenia

March 1, 2022

Drawing on 4 RCTs and 2 open-label extension studies of brexpiprazole, this analysis looks at the effects of this medication on functioning both in the short term and over...
, , , et al
JCP
Original Research

Brexpiprazole in MDD—Metabolic Parameters and Weight

October 1, 2019

Adjunctive atypical antipsychotics can increase antidepressant response in depressed patients, but may cause adverse metabolic effects. This study examines the metabolic effects of adjunctive brexpiprazole in patients with major...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe